Risk Evaluation of EMT and Inflammation in Metastatic Pancreatic Cancer Cells Following Plasma Treatment
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Frontiers in Physics, 8, 2020
- Schlagwort
-
-
- Ereignis
-
Veröffentlichung
- (wo)
-
Greifswald
- (wer)
-
Universität Greifswald
- (wann)
-
2020
- Urheber
-
Freund, Eric
Spadola, Chiara
Schmidt, Anke
Privat-Maldonado, Angela
Bogaerts, Annemie
von Woedtke, Thomas
Weltmann, Klaus-Dieter
Heidecke, Claus-Dieter
Partecke, Lars-Ivo
Käding, André
Bekeschus, Sander
- DOI
-
10.3389/fphy.2020.569618
- URN
-
urn:nbn:de:gbv:9-opus-40105
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:52 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Freund, Eric
- Spadola, Chiara
- Schmidt, Anke
- Privat-Maldonado, Angela
- Bogaerts, Annemie
- von Woedtke, Thomas
- Weltmann, Klaus-Dieter
- Heidecke, Claus-Dieter
- Partecke, Lars-Ivo
- Käding, André
- Bekeschus, Sander
- Universität Greifswald
Entstanden
- 2020
Ähnliche Objekte (12)
Systemic therapy for metastatic pancreatic cancer
New Advances in the Treatment of Metastatic Pancreatic Cancer
EMT-specific circulating micro RNAs and circulating tumor cells in metastatic breast cancer
Txnrd2 deficiency inhibits Epithelial-to-Mesenchymal-Transition (EMT) in pancreatic ductal adenocarcinoma (PDAC)
Deciphering the roles of LGR6 in WNT and EMT signaling in pancreatic cancer
EMtE
EmT
The contribution of epithelial to mesenchymal transition (EMT) to the metastases of pancreatic cancer
Orchestrating Treatment Modalities in Metastatic Pancreatic Neuroendocrine Tumors—Need for a Conductor
The discovery of genes that exhibit strong effects on metastatic pancreatic cancer
Loss of interleukin-13-receptor-alpha-1 induces apoptosis and promotes EMT in pancreatic cancer
Changes in pancreatic fat content following diet-induced weight loss
Systemic therapy for metastatic pancreatic cancer
New Advances in the Treatment of Metastatic Pancreatic Cancer
EMT-specific circulating micro RNAs and circulating tumor cells in metastatic breast cancer
Txnrd2 deficiency inhibits Epithelial-to-Mesenchymal-Transition (EMT) in pancreatic ductal adenocarcinoma (PDAC)
Deciphering the roles of LGR6 in WNT and EMT signaling in pancreatic cancer
EMtE
EmT
The contribution of epithelial to mesenchymal transition (EMT) to the metastases of pancreatic cancer
Orchestrating Treatment Modalities in Metastatic Pancreatic Neuroendocrine Tumors—Need for a Conductor
The discovery of genes that exhibit strong effects on metastatic pancreatic cancer
Loss of interleukin-13-receptor-alpha-1 induces apoptosis and promotes EMT in pancreatic cancer
Changes in pancreatic fat content following diet-induced weight loss
Systemic therapy for metastatic pancreatic cancer
New Advances in the Treatment of Metastatic Pancreatic Cancer
EMT-specific circulating micro RNAs and circulating tumor cells in metastatic breast cancer
Txnrd2 deficiency inhibits Epithelial-to-Mesenchymal-Transition (EMT) in pancreatic ductal adenocarcinoma (PDAC)
Deciphering the roles of LGR6 in WNT and EMT signaling in pancreatic cancer
EMtE
EmT
The contribution of epithelial to mesenchymal transition (EMT) to the metastases of pancreatic cancer
Orchestrating Treatment Modalities in Metastatic Pancreatic Neuroendocrine Tumors—Need for a Conductor
The discovery of genes that exhibit strong effects on metastatic pancreatic cancer
Loss of interleukin-13-receptor-alpha-1 induces apoptosis and promotes EMT in pancreatic cancer